Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer.

Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D'Amato NC, Elias A, Richer JK.

Cancer Res. 2017 Jul 1;77(13):3455-3466. doi: 10.1158/0008-5472.CAN-16-3240. Epub 2017 May 16.

2.

Outpatient Anesthetic Safety Considerations for Obstructive Sleep Apnea.

Butterfield KJ.

Oral Maxillofac Surg Clin North Am. 2017 May;29(2):189-196. doi: 10.1016/j.coms.2016.12.007. Review.

PMID:
28417891
3.

MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.

Christenson JL, Butterfield KT, Spoelstra NS, Norris JD, Josan JS, Pollock JA, McDonnell DP, Katzenellenbogen BS, Katzenellenbogen JA, Richer JK.

Horm Cancer. 2017 Apr;8(2):69-77. doi: 10.1007/s12672-017-0285-6. Epub 2017 Feb 13.

4.

Serum Progesterone Levels in Pregnant Women with Obstructive Sleep Apnea: A Case Control Study.

Lee J, Eklund EE, Lambert-Messerlian G, Palomaki GE, Butterfield K, Curran P, Bourjeily G.

J Womens Health (Larchmt). 2017 Mar;26(3):259-265. doi: 10.1089/jwh.2016.5917. Epub 2017 Jan 19.

5.

Effects of 13-Hour Hyperglucagonemia on Energy Expenditure and Hepatic Glucose Production in Humans.

Chakravarthy M, Parsons S, Lassman ME, Butterfield K, Lee AY, Chen Y, Previs S, Spond J, Yang S, Bock C, Yi F, Moon J, Wohlers-Kariesch E, Smith SR, Meyer C.

Diabetes. 2017 Jan;66(1):36-44. doi: 10.2337/db16-0746. Epub 2016 Oct 7.

6.

Constitutive expression of microRNA-150 in mammary epithelium suppresses secretory activation and impairs de novo lipogenesis.

Heinz RE, Rudolph MC, Ramanathan P, Spoelstra NS, Butterfield KT, Webb PG, Babbs BL, Gao H, Chen S, Gordon MA, Anderson SM, Neville MC, Gu H, Richer JK.

Development. 2016 Nov 15;143(22):4236-4248. Epub 2016 Oct 11.

7.

Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.

Krishna R, East L, Larson P, Valiathan C, Butterfield K, Teng Y, Hernandez-Illas M.

J Pharm Pharmacol. 2016 Nov;68(11):1359-1365. doi: 10.1111/jphp.12632. Epub 2016 Sep 27.

PMID:
27671833
8.

Quality of Life Assessment After Maxillomandibular Advancement Surgery for Obstructive Sleep Apnea.

Butterfield KJ, Marks PL, McLean L, Newton J.

J Oral Maxillofac Surg. 2016 Jun;74(6):1228-37. doi: 10.1016/j.joms.2016.01.043. Epub 2016 Jan 30.

PMID:
26917205
9.

Linear and volumetric airway changes after maxillomandibular advancement for obstructive sleep apnea.

Butterfield KJ, Marks PL, McLean L, Newton J.

J Oral Maxillofac Surg. 2015 Jun;73(6):1133-42. doi: 10.1016/j.joms.2014.11.020. Epub 2014 Dec 13.

PMID:
25795186
10.

Pharyngeal airway morphology in healthy individuals and in obstructive sleep apnea patients treated with maxillomandibular advancement: a comparative study.

Butterfield KJ, Marks PL, McLean L, Newton J.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Mar;119(3):285-92. doi: 10.1016/j.oooo.2014.11.016. Epub 2014 Dec 5.

PMID:
25592868
11.

Caregiver presence and patient completion of a transitional care intervention.

Epstein-Lubow G, Baier RR, Butterfield K, Gardner R, Babalola E, Coleman EA, Gravenstein S.

Am J Manag Care. 2014 Oct 1;20(10):e349-444.

12.

Placenta-secreted circulating markers in pregnant women with obstructive sleep apnea.

Bourjeily G, Curran P, Butterfield K, Maredia H, Carpenter M, Lambert-Messerlian G.

J Perinat Med. 2015 Jan;43(1):81-7. doi: 10.1515/jpm-2014-0052.

PMID:
24846956
13.

Obstructive sleep apnea is associated with alterations in markers of fetoplacental wellbeing.

Bourjeily G, Butterfield K, Curran P, Lambert-Messerlian G.

J Matern Fetal Neonatal Med. 2015 Feb;28(3):262-6. doi: 10.3109/14767058.2014.913131. Epub 2014 May 14.

PMID:
24712853
14.

Association of dementia with early rehospitalization among Medicare beneficiaries.

Daiello LA, Gardner R, Epstein-Lubow G, Butterfield K, Gravenstein S.

Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):162-8. doi: 10.1016/j.archger.2014.02.010. Epub 2014 Mar 11.

PMID:
24661400
15.

Is implementation of the care transitions intervention associated with cost avoidance after hospital discharge?

Gardner R, Li Q, Baier RR, Butterfield K, Coleman EA, Gravenstein S.

J Gen Intern Med. 2014 Jun;29(6):878-84. doi: 10.1007/s11606-014-2814-0. Epub 2014 Mar 4.

16.

Recruiting hospitalized patients for research: how do participants differ from eligible nonparticipants?

Voss R, Gravenstein S, Baier R, Butterfield K, Epstein-Lubow G, Shamji H, Gardner R.

J Hosp Med. 2013 Apr;8(4):208-14. doi: 10.1002/jhm.2024.

PMID:
23559503
17.

Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.

Kuchuk I, Mazzarello S, Butterfield K, Appleton A, Addison CL, Clemons M.

J Bone Oncol. 2013 Jan 1;2(1):38-46. doi: 10.1016/j.jbo.2012.12.001. eCollection 2013 Feb. Review.

18.

Equivalent dynamic human brain NK1-receptor occupancy following single-dose i.v. fosaprepitant vs. oral aprepitant as assessed by PET imaging.

Van Laere K, De Hoon J, Bormans G, Koole M, Derdelinckx I, De Lepeleire I, Declercq R, Sanabria Bohorquez SM, Hamill T, Mozley PD, Tatosian D, Xie W, Liu Y, Liu F, Zappacosta P, Mahon C, Butterfield KL, Rosen LB, Murphy MG, Hargreaves RJ, Wagner JA, Shadle CR.

Clin Pharmacol Ther. 2012 Aug;92(2):243-50. doi: 10.1038/clpt.2012.62. Epub 2012 Jun 27.

PMID:
22739139
19.

Development of affinity-based delivery of NGF from a chondroitin sulfate biomaterial.

Butterfield KC, Conovaloff AW, Panitch A.

Biomatter. 2011 Oct-Dec;1(2):174-81. doi: 10.4161/biom.18791.

20.

The care transitions intervention: translating from efficacy to effectiveness.

Voss R, Gardner R, Baier R, Butterfield K, Lehrman S, Gravenstein S.

Arch Intern Med. 2011 Jul 25;171(14):1232-7. doi: 10.1001/archinternmed.2011.278.

PMID:
21788540
21.

Gender differences of airway dimensions in anatomically matched sites on CT in smokers.

Kim YI, Schroeder J, Lynch D, Newell J, Make B, Friedlander A, Estépar RS, Hanania NA, Washko G, Murphy JR, Wilson C, Hokanson JE, Zach J, Butterfield K, Bowler RP, Copdgene Investigators.

COPD. 2011 Aug;8(4):285-92. doi: 10.3109/15412555.2011.586658. Epub 2011 Jul 14.

22.

Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.

Behm MO, Blanchard RL, Murphy MG, Palcza JS, Harris DE, Butterfield KL, Smith WB, Preston RA, Chodakewitz JA, Krucoff MW.

Headache. 2011 Jun;51(6):954-60. doi: 10.1111/j.1526-4610.2011.01901.x.

PMID:
21631478
23.

Reducing the incidence of Clostridium difficile infections: can we do it?

Pop-Vicas A, Butterfield K, Gardner R.

Med Health R I. 2010 Sep;93(9):263-6. No abstract available.

PMID:
20957908
24.

Endogenous enzymes (NOX and ECSOD) regulate smoke-induced oxidative stress.

Tollefson AK, Oberley-Deegan RE, Butterfield KT, Nicks ME, Weaver MR, Remigio LK, Decsesznak J, Chu HW, Bratton DL, Riches DW, Bowler RP.

Free Radic Biol Med. 2010 Dec 15;49(12):1937-46. doi: 10.1016/j.freeradbiomed.2010.09.022. Epub 2010 Sep 29.

25.

Chondroitin sulfate-binding peptides block chondroitin 6-sulfate inhibition of cortical neurite growth.

Butterfield KC, Conovaloff A, Caplan M, Panitch A.

Neurosci Lett. 2010 Jul 5;478(2):82-7. doi: 10.1016/j.neulet.2010.04.070. Epub 2010 May 5.

PMID:
20450957
26.

Identification and sequence composition characterization of chondroitin sulfate-binding peptides through peptide array screening.

Butterfield KC, Caplan M, Panitch A.

Biochemistry. 2010 Feb 23;49(7):1549-55. doi: 10.1021/bi9021044.

PMID:
20095636
27.

Identifying star performers: the relationship between ambitious targets and nursing home quality improvement.

Baier R, Butterfield K, Patry G, Harris Y, Gravenstein S.

J Am Geriatr Soc. 2009 Aug;57(8):1498-503. doi: 10.1111/j.1532-5415.2009.02362.x. Epub 2009 Jun 22.

PMID:
19549019
28.

Aiming for star performance: the relationship between setting targets and improved nursing home quality of care.

Baier RR, Butterfield K, Harris Y, Gravenstein S.

J Am Med Dir Assoc. 2008 Oct;9(8):594-8. doi: 10.1016/j.jamda.2008.06.008. Epub 2008 Sep 7.

PMID:
19083294
29.

A novel assay to probe heparin-peptide interactions using pentapeptide-stabilized gold nanoparticles.

Jeong KJ, Butterfield K, Panitch A.

Langmuir. 2008 Aug 19;24(16):8794-800. doi: 10.1021/la801198p. Epub 2008 Jul 22.

PMID:
18646727
30.

Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.

DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD.

J Gen Intern Med. 2008 Feb;23(2):169-74. Epub 2007 Dec 21.

31.

Effect of platelet-rich plasma with autogenous bone graft for maxillary sinus augmentation in a rabbit model.

Butterfield KJ, Bennett J, Gronowicz G, Adams D.

J Oral Maxillofac Surg. 2005 Mar;63(3):370-6.

PMID:
15742289
32.

Inheritance and segregation of virus and herbicide resistance transgenes in sugarcane.

Butterfield K, Irvine E, Valdez Garza M, Mirkov E.

Theor Appl Genet. 2002 Apr;104(5):797-803. Epub 2002 Feb 8.

PMID:
12582639
33.

Streptococcal infection of the temporomandibular joint of hematogenous origin: a case report and contemporary therapy.

Goldschmidt MJ, Butterfield KJ, Goracy ES, Goldberg MH.

J Oral Maxillofac Surg. 2002 Nov;60(11):1347-53. Review. No abstract available.

PMID:
12420272
34.

A study to investigate the ability of subjects with chronic lung diseases to activate the roadside Lion Alcolmeter SL-400.

Honeybourne D, Moore AJ, Butterfield K, Azzan L.

Med Sci Law. 1999 Oct;39(4):337-41.

PMID:
10581914
35.

Linear tomography's clinical accuracy and validity for presurgical dental implant analysis.

Butterfield KJ, Dagenais M, Clokie C.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Aug;84(2):203-9.

PMID:
9269023
36.

Branching ratio of the H-(n=2) shape resonance.

Halka M, Bryant HC, Johnstone C, Marchini B, Miller W, Mohagheghi AH, Tang CY, Butterfield KB, Clark DA, Cohen S, Donahue JB, Gram PA, Hamm RW, Hsu A, MacArthur DW, MacKerrow EP, Quick CR, Tiee J, Rózsa K.

Phys Rev A. 1992 Dec 1;46(11):6942-6948. No abstract available.

PMID:
9908027
37.

Long-range alpha detector.

MacArthur DW, Allander KS, Bounds JA, Butterfield KB, McAtee JL.

Health Phys. 1992 Sep;63(3):324-30.

PMID:
1644569
38.

Analysis of biological samples using prompt gamma radiations induced by 14.7-MeV neutrons.

Hollas CL, Ussery LE, Butterfield KB, Morgado RE.

Biol Trace Elem Res. 1990 Jul-Dec;26-27:103-10.

PMID:
1704709
39.

The effects of chronic obstructive airways disease on the ability to drive and to use a roadside alcolmeter.

Briggs JE, Patel H, Butterfield K, Honeybourne D.

Respir Med. 1990 Jan;84(1):43-6.

PMID:
2371420
40.

A method for in vivo determination of carbon and oxygen using prompt gamma radiations induced by 14.7-MeV neutrons.

Hollas CL, Ussery LE, Butterfield KB, Morgado RE.

Basic Life Sci. 1990;55:395-400. No abstract available.

PMID:
2088299
41.

A subset of memory CD4+ helper T lymphocytes identified by expression of Pgp-1.

Butterfield K, Fathman CG, Budd RC.

J Exp Med. 1989 Apr 1;169(4):1461-6.

42.

Ultrahigh-energy pulsed emission from Hercules X-1 with anomalous air-shower muon production.

Dingus BL, Alexandreas DE, Allen RC, Burman RL, Butterfield KB, Cady R, Chang CY, Ellsworth RW, Goodman JA, Gupta SK, Haines TJ, Krakauer DA, Lloyd-Evans J, Nagle DE, Potter M, Sandberg VD, Talaga RL, Wilkinson CA, Yodh GB.

Phys Rev Lett. 1988 Oct 24;61(17):1906-1909. No abstract available.

PMID:
10038929
43.

Search for signals from Cygnus X-3 at energies above 50 TeV.

Dingus BL, Chang CY, Goodman JA, Gupta SK, Krakauer DA, Talaga RL, Yodh GB, Ellsworth RW, Burman RL, Butterfield KB, Cady R, Carlini RD, Lloyd-Evans J, Nagle DE, Sandberg VD, Wilkinson CA, Linsley J, Allen RC.

Phys Rev Lett. 1988 May 2;60(18):1785-1788. No abstract available.

PMID:
10038140
44.

Response of the 1Po resonance near n=3 in the H- continuum to external electric fields.

Cohen S, Bryant HC, Harvey CJ, Stewart JE, Butterfield KB, Clark DA, Donahue JB, MacArthur DW, Comtet G, Smith WW.

Phys Rev A Gen Phys. 1987 Nov 15;36(10):4728-4736. No abstract available.

PMID:
9898733
45.

Stability of the 1P o shape resonance in H- in moderate electric fields.

Comtet G, Harvey CJ, Stewart JE, Bryant HC, Butterfield KB, Clark DA, Donahue JB, Gram PA, MacArthur DW, Yuan V V, Smith WW, Cohen S.

Phys Rev A Gen Phys. 1987 Feb 15;35(4):1547-1554. No abstract available.

PMID:
9898313
46.

Test of the special-relativistic Doppler formula at beta =0.84.

MacArthur DW, Butterfield KB, Clark DA, Donahue JB, Gram PA, Bryant HC, Harvey CJ, Smith WW, Comtet G.

Phys Rev Lett. 1986 Jan 27;56(4):282-285. No abstract available.

PMID:
10033147
47.

Energy measurement of the lowest 1P0 Feshbach resonance in H-

MacArthur DW, Butterfield KB, Clark DA, Donahue JB, Gram PA, Bryant HC, Harvey CJ, Smith WW, Comtet G.

Phys Rev A Gen Phys. 1985 Sep;32(3):1921-1923. No abstract available.

PMID:
9896299
48.

Collaborative scheme for tissue typing and matching in renal transplantation, XI. Role of HLA-A, B, DR, and D matching and other factors on 899 cadaver kidney grafts.

Festenstein H, Sachs JA, Butterfield K, Yeatman N, Holmes J.

Transplant Proc. 1981 Mar;13(1 Pt 2):934-7. No abstract available.

PMID:
7022964

Supplemental Content

Loading ...
Support Center